Type 2 Diabetes

A trial of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment.

An RCT of patients with prediabetes and OSA details the cardiovascular benefit of optimized CPAP treatment in this patient population.

Gregory Weiss, MD, reflects on the idea of creating a cardiometabolic subspecialty.

An analysis of nationally representative data suggests 35.6% of diabetic patients reported not receiving a yearly influenza vaccination.

Results of a study of more than 330 patients suggest use of sitagliptin could improve outcomes in patients with diabetes and COVID-19.

This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.

An analysis of nearly 300k offspring suggests those exposed to diabetes in the womb were at an increased risk of cardiovascular disease events and risk factors in young adulthood.

Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes

An analysis of data from 5 major databases suggests NRTIs could reduce incidence of type 2 diabetes.

An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

Analysis of information from more than 1000 patients in Australia sheds light on the potential association between metformin use and slower cognitive decline in older individuals.

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

New research suggests children treated with high-doses of oral glucocorticoids could be at a greater risk of diabetes, hypertension, and venous thromboembolism.

Analysis of data from a European aging study suggests feeling lonely was linked to an increased risk of developing diabetes in older adults.

An analysis of more than 1100 children suggests those born to mothers with gestational diabetes mellitus were at increased risk of accelerated aging.

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

An interview examining the use of coronary artery calcium scores for predicting CV events and stroke risk in real-world settings.

A study from ESC Congress 2020 dove deeper into associations between specific biomarkers and risk of CV events in CAD patients with and without diabetes.

Melissa Young, MD, offers perspective on the push to create cardiometabolic fellowships versus making endocrinology a more desirable field.

An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use.

Full results of DAPA-CKD further inform clinicians on dapagliflozin and use of SGLT2 inhibitors in those with and without diabetes.